Menu

Markets

Research

News

Learn
Paper trading
AI Chat
Get the app WatchlistsPortfoliosAlerts
Sign in

NervGen Pharma Corp. NGEN

Full chart Compare
Set alert

Price alert · NGEN

All alert types
1.32 USD -0.03 (-2.22%)

At closeNov 3, 2026, 4:00 PM EST

1.32 0.00 0.00%

After hours · Nov 3, 4:00 PM ET

1.28 Day range 1.37
1.28 52-week range 6.30
YTD
-76.43%
1 year
-46.12%

Financial health

Altman Z-Score

-1.33 Distress zone

Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.

Piotroski F-Score

2 / 9 Weak

Nine pass/fail tests of profitability, leverage and efficiency.

FMP rating

D+1 / 5 overall

  • DCF 2
  • Return on Equity 1
  • Return on Assets 1
  • Debt / Equity 1
  • P/E 1
  • P/B 1

Valuation

P/E -12.6×
FY 2017: -12193×FY 2018: -117×FY 2019: -14.2×FY 2020: -16.0×FY 2021: -16.4×FY 2022: -14.8×FY 2023: -15.3×FY 2024: -17.1×FY 2025: -12.6×
FY 2017 5y median -15.3× FY 2025
P/S 0.0×
FY 2017: 0.0×FY 2018: 0.0×FY 2019: 0.0×FY 2020: 0.0×FY 2021: 0.0×FY 2022: 0.0×FY 2023: 0.0×FY 2024: 0.0×FY 2025: 0.0×
FY 2017 5y median 0.0× FY 2025
P/B 160×
FY 2017: 0.0×FY 2018: 63.2×FY 2019: 23.9×FY 2020: 29.5×FY 2021: 12.5×FY 2022: 22.8×FY 2023: -167×FY 2024: 161×FY 2025: 160×
FY 2017 5y median 22.8× FY 2025
P/FCF -28.5×
FY 2017: 0.0×FY 2018: -153×FY 2019: -17.3×FY 2020: -27.7×FY 2021: -25.4×FY 2022: -17.2×FY 2023: -29.7×FY 2024: -24.6×FY 2025: -28.5×
FY 2017 5y median -25.4× FY 2025
EV/EBITDA -94.4×
FY 2017: 0.0×FY 2018: -117×FY 2019: -13.9×FY 2020: -15.2×FY 2021: -15.3×FY 2022: -14.2×FY 2023: -14.6×FY 2024: -16.6×FY 2025: -94.4×
FY 2017 5y median -15.3× FY 2025
EV/Sales 0.0×
FY 2017: 0.0×FY 2018: 0.0×FY 2019: 0.0×FY 2020: 0.0×FY 2021: 0.0×FY 2022: 0.0×FY 2023: 0.0×FY 2024: 0.0×FY 2025: 0.0×
FY 2017 5y median 0.0× FY 2025
FCF Yield -3.5%
FY 2017: 0.0%FY 2018: -0.7%FY 2019: -5.8%FY 2020: -3.6%FY 2021: -3.9%FY 2022: -5.8%FY 2023: -3.4%FY 2024: -4.1%FY 2025: -3.5%
FY 2017 5y median -3.9% FY 2025

Profitability

Gross Margin 0.0%
FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2017 5y median 0.0% FY 2025
Operating Margin 0.0%
FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2017 5y median 0.0% FY 2025
Net Margin 0.0%
FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2017 5y median 0.0% FY 2025
ROE -1268.9%
FY 2017: 0.0%FY 2018: -54.0%FY 2019: -167.2%FY 2020: -188.9%FY 2021: -75.7%FY 2022: -153.9%FY 2023: 1114.0%FY 2024: -931.7%FY 2025: -1268.9%
FY 2017 5y median -153.9% FY 2025
ROIC -719.6%
FY 2017: 0.0%FY 2018: -51.3%FY 2019: -168.9%FY 2020: -189.1%FY 2021: -76.2%FY 2022: -167.5%FY 2023: 981.1%FY 2024: -929.5%FY 2025: -719.6%
FY 2017 5y median -167.5% FY 2025
ROA -190.1%
FY 2017: 0.0%FY 2018: -43.9%FY 2019: -144.3%FY 2020: -167.6%FY 2021: -71.1%FY 2022: -86.8%FY 2023: -169.1%FY 2024: -123.2%FY 2025: -190.1%
FY 2017 5y median -123.2% FY 2025

Growth (YoY)

Revenue 0.0%
FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2017 FY 2025
Operating Income -0.7%
FY 2017: 0.0%FY 2018: -11198.9%FY 2019: -648.3%FY 2020: -10.7%FY 2021: -15.0%FY 2022: -76.8%FY 2023: 22.1%FY 2024: -40.1%FY 2025: -0.7%
FY 2017 FY 2025
EPS (diluted) -69.4%
FY 2017: 0.0%FY 2018: 0.0%FY 2019: -684.7%FY 2020: 12.8%FY 2021: 2.9%FY 2022: -18.2%FY 2023: 5.1%FY 2024: 2.7%FY 2025: -69.4%
FY 2017 FY 2025
Free Cash Flow -15.9%
FY 2017: 0.0%FY 2018: 0.0%FY 2019: -702.0%FY 2020: 23.9%FY 2021: -31.8%FY 2022: -111.7%FY 2023: 36.0%FY 2024: -48.9%FY 2025: -15.9%
FY 2017 FY 2025

Financial Health

Current Ratio 1.2×
FY 2017: 0.0×FY 2018: 5.7×FY 2019: 6.8×FY 2020: 8.2×FY 2021: 16.2×FY 2022: 2.3×FY 2023: 0.8×FY 2024: 1.1×FY 2025: 1.2×
FY 2017 5y median 1.2× FY 2025
Quick Ratio 1.2×
FY 2017: 0.0×FY 2018: 5.7×FY 2019: 6.8×FY 2020: 8.2×FY 2021: 16.2×FY 2022: 2.3×FY 2023: 0.8×FY 2024: 1.1×FY 2025: 1.2×
FY 2017 5y median 1.2× FY 2025
Debt / Equity 0.0×
FY 2017: 0.0×FY 2018: 0.0×FY 2019: 0.0×FY 2020: 0.0×FY 2021: 0.0×FY 2022: 0.0×FY 2023: -0.1×FY 2024: 0.0×FY 2025: 0.0×
FY 2017 5y median 0.0× FY 2025
Net Debt / EBITDA 3.9×
FY 2017: 0.0×FY 2018: 1.8×FY 2019: 0.4×FY 2020: 0.5×FY 2021: 1.3×FY 2022: 1.1×FY 2023: 0.5×FY 2024: 0.7×FY 2025: 3.9×
FY 2017 5y median 1.1× FY 2025
Interest Coverage 0.0×
FY 2017: 0.0×FY 2018: 0.0×FY 2019: 0.0×FY 2020: 0.0×FY 2021: 0.0×FY 2022: -44.7×FY 2023: 0.0×FY 2024: 0.0×FY 2025: 0.0×
FY 2017 5y median 0.0× FY 2025

Dividends

Dividend Yield 0.0%
FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2017 5y median 0.0% FY 2025
Payout Ratio 0.0%
FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2017 5y median 0.0% FY 2025

Annual · latest fiscal year ends 2025-12-31